Spine Care Technologies Inc. (“SCT”) was founded in March 2018 by Roland Kiser and his former banking partner James Fitzgerald. Kiser seized on the opportunity to become fully engaged in the next generation spine care technology by applying a drug-free approach to treatment of musculoskeletal pain.

According to the publicly available medical research documentation, musculoskeletal pain, led by spinal disorders, costs the U.S. health care system $874 billion per year, and is the most common cause of severe long-term pain and disability.

SCT markets and distributes it’s flagship product, Extentrac® Elite, FDA cleared as a Medical Class II Device.

Extentrac® enjoys a proven record of safety and effectiveness in non-surgical, drug free, disc and spine care treatment. Health professionals worldwide have confirmed excellence in clinical outcomes in the management of low back pain in both private and hospital physical rehabilitation facilities through the utilization of Extentrac®.

Kiser is supported by successful business executives with expertise in investment banking, engineering & technology inventions, operations, manufacturing, legal and medical device and sports sector.